Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa.

Schnippel K, Meyer-Rath G, Long L, MacLeod W, Sanne I, Stevens WS, Rosen S.

Trop Med Int Health. 2012 Sep;17(9):1142-51. doi: 10.1111/j.1365-3156.2012.03028.x. Epub 2012 Jun 12.

PMID:
22686606
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.

Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, Dowdy D, Pym A, Mwaba P, Mason P, Peter J, Dheda K; TB-NEAT team.

Lancet. 2014 Feb 1;383(9915):424-35. doi: 10.1016/S0140-6736(13)62073-5. Epub 2013 Oct 28.

PMID:
24176144
[PubMed - indexed for MEDLINE]
3.

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.

Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA.

PLoS Med. 2012;9(11):e1001347. doi: 10.1371/journal.pmed.1001347. Epub 2012 Nov 20.

PMID:
23185139
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.

Van Rie A, Page-Shipp L, Hanrahan CF, Schnippel K, Dansey H, Bassett J, Clouse K, Scott L, Stevens W, Sanne I.

Int J Tuberc Lung Dis. 2013 Mar;17(3):368-72. doi: 10.5588/ijtld.12.0392.

PMID:
23407225
[PubMed - indexed for MEDLINE]
5.

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W.

PLoS Med. 2011 Jul;8(7):e1001061. doi: 10.1371/journal.pmed.1001061. Epub 2011 Jul 26.

PMID:
21814495
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa.

Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S.

PLoS One. 2012;7(5):e36966. doi: 10.1371/journal.pone.0036966. Epub 2012 May 31.

PMID:
22693561
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A.

PLoS One. 2013 Jun 6;8(6):e65421. doi: 10.1371/journal.pone.0065421. Print 2013.

PMID:
23762367
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F.

PLoS Med. 2011 Nov;8(11):e1001120. doi: 10.1371/journal.pmed.1001120. Epub 2011 Nov 8.

PMID:
22087078
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa.

Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S.

S Afr Med J. 2013 Jan 14;103(2):101-6. doi: 10.7196/samj.6182.

PMID:
23374320
[PubMed - indexed for MEDLINE]
10.

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K.

Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14.

PMID:
21493734
[PubMed - indexed for MEDLINE]
11.

Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.

Bates M, O'Grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, Kasonde R, Mulota P, Mzyece J, Chomba M, Mukonda L, Mumba M, Kapata N, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A.

Lancet Infect Dis. 2013 Jan;13(1):36-42. doi: 10.1016/S1473-3099(12)70245-1. Epub 2012 Nov 5.

PMID:
23134697
[PubMed - indexed for MEDLINE]
12.

Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey.

Dorman SE, Chihota VN, Lewis JJ, Shah M, Clark D, Grant AD, Churchyard GJ, Fielding KL.

PLoS One. 2012;7(8):e43307. doi: 10.1371/journal.pone.0043307. Epub 2012 Aug 15.

PMID:
22905254
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid.

Theron G, Peter J, Meldau R, Khalfey H, Gina P, Matinyena B, Lenders L, Calligaro G, Allwood B, Symons G, Govender U, Setshedi M, Dheda K.

Thorax. 2013 Nov;68(11):1043-51. doi: 10.1136/thoraxjnl-2013-203485. Epub 2013 Jun 29.

PMID:
23811536
[PubMed - indexed for MEDLINE]
14.

Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.

Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P.

Trials. 2013 Jun 12;14:170. doi: 10.1186/1745-6215-14-170.

PMID:
23758662
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.

Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ.

Lancet Infect Dis. 2011 Nov;11(11):819-24. doi: 10.1016/S1473-3099(11)70167-0. Epub 2011 Jul 19.

PMID:
21764384
[PubMed - indexed for MEDLINE]
Free Article
16.

Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.

Clouse K, Page-Shipp L, Dansey H, Moatlhodi B, Scott L, Bassett J, Stevens W, Sanne I, Van Rie A.

S Afr Med J. 2012 Sep 7;102(10):805-7. doi: 10.7196/samj.5851.

PMID:
23034211
[PubMed - indexed for MEDLINE]
17.

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

Theron G, Pooran A, Peter J, van Zyl-Smit R, Kumar Mishra H, Meldau R, Calligaro G, Allwood B, Sharma SK, Dawson R, Dheda K.

Eur Respir J. 2012 Jul;40(1):161-8. doi: 10.1183/09031936.00145511. Epub 2011 Nov 10.

PMID:
22075479
[PubMed - indexed for MEDLINE]
Free Article
18.

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.

Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA, Horsburgh CR, Losina E, Freedberg KA, Walensky RP.

AIDS. 2012 May 15;26(8):987-95. doi: 10.1097/QAD.0b013e3283522d47.

PMID:
22333751
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.

O'Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A.

Clin Infect Dis. 2012 Nov;55(9):1171-8. doi: 10.1093/cid/cis631. Epub 2012 Jul 17. Erratum in: Clin Infect Dis. 2013 Jan;56(2):313.

PMID:
22806590
[PubMed - indexed for MEDLINE]
Free Article
20.

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa.

Shah M, Chihota V, Coetzee G, Churchyard G, Dorman SE.

BMC Infect Dis. 2013 Jul 29;13:352. doi: 10.1186/1471-2334-13-352.

PMID:
23895665
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk